Recent Product Launches HTG Molecular Diagnostics has recently launched innovative products like the HTG EdgeSeq mouse miRNA whole transcriptome test and the HTG Transcriptome Panel, creating opportunities for sales growth through these new offerings.

Collaborations and Partnerships Partnerships with companies like OmiCure present avenues for strategic alliances and potentially joint sales efforts to tap into new markets and offer combined solutions to customers.

White Paper Releases The release of proof-of-approach white papers demonstrates thought leadership and a deep understanding of the industry, providing content that can be leveraged in sales conversations to showcase expertise and attract customers.

Board of Directors Appointment The addition of Christopher P. Kiritsy to the Board of Directors brings in fresh perspectives and valuable connections, which can be leveraged for networking and exploring new business opportunities.

Financial Health and Funding With recent financing of $10 million through public offerings and a revenue range of $10-50 million, HTG Molecular Diagnostics shows stability and growth potential, indicating a solid foundation for sales expansion and investments.